Lower WASP expression in PBMC from CML patients in advanced phases correlates with poor OS and re-expression of WASP negatively modulates BCR–ABL1-induced tumorigenesis in vitro and in vivo. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.